READ ARTICLE

Dysport Approved for Lower Limb Spasticity

The FDA has expanded the indication of Dysport (abobotulinumtoxinA, Ipsen Biopharmaceuticals) to include lower limb spasticity. In a Phase 3 study, adult patients treated with Dysport following a stroke or traumatic brain injury showed improvement in muscle tone at the ankle joint at four weeks. The…

READ ARTICLE

Phase 3 Results Published for Investigational Levodopa-Induced Dyskinesia Treatment

READ ARTICLE

AHS 2017: Amgen’s CGRP Inhibitor Reduces Migraine Days

READ ARTICLE

American Epilepsy Society Awards Investigators for Early Career Research

READ ARTICLE

Anti-Alpha-Synuclein Antibody Shows Early Potential as Parkinson’s DMT

Contact Info

For advertising rates and opportunities:
Wendy Terry
Publisher
217-652-3859
wterry@bmctoday.com

Steve Farrell
National Sales Manager
973-768-8681
sfarrell@bmctoday.com

About Practical Neurology

Launched in January 2002, Practical Neurology strives to enhance quality of care and improve the daily operation of neurology practices. Each month, our experts explain the real-world significance of recent advances in neurologic science and offer step-by-step advice on how to overcome the clinical and business challenges neurologists face. Our straightforward, how-to articles give neurologists tools they can put into practice right away.

 
  • BRYN MAWR COMMUNICATIONS III, LLC